Immune response in mild versus severe COVID-19 infections
A study by researchers at Stanford University and other institutions reveals how the immune system goes awry leading to severe ...
Olink Proteomics and WuXi NextCODE announce strategic cooperation
With this new and important collaboration, customers in China will have access to run Olink fee for service projects in ...
Systems-level immunomonitoring of severe COVID-19
A study by Petter Brodin’s group at the Karolinska Institute in Stockholm has used a longitudinal, systems-level approach ...
Free Olink statistical analysis app available
Olink® Insights Stat Analysis is a web-based tool for basic data visualizations and statistical analyses and is based on ...
PEA on NGS, a game-changer for proteomics
In our efforts to enable the understanding of real-time human biology through accelerating proteomics, we are very proud to ...
ACE2 – protein of the moment
Two recent publications have reported important new data on ACE2, the cellular receptor protein for the SARS-CoV-2 virus.
COVID-19 Technology Access Framework
Olink has been acknowledged as a critically important technology used in the 'COVID-19 Technology Access Framework', organized by Harvard ...
ACE inhibition and COVID-19: a Mendelian Randomization study
A study from Gill et al has found no evidence to support the hypothesis that the commonly used hypertension drugs ...
Large-scale pQTL study from SCALLOP
Beyond Mass Spec: Genomeweb article March 2020
Protein data points generated
Publications listed on website